Key facts
- This page summarizes Thomas Charles Reilly's Form 4 filing for AMARIN CORP PLC\UK (AMRN).
- 2 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 09 Feb 2024, 16:30.
Thomas Charles Reilly - 01 Feb 2024 Form 4 Insider Report for AMARIN CORP PLC\UK (AMRN)
- Reporting relationship
- EVP and CFO
- Issuer ticker
- AMRN
- Reported as of
- 01 Feb 2024
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 09 Feb 2024, 16:30:28 UTC
- Prior SEC filing
- 02 Feb 2024
- Next SEC filing
- 21 Jun 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Tom Reilly, by power of attorney
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Thomas Charles Reilly filed Form 4 for AMARIN CORP PLC\UK (AMRN) on 09 Feb 2024.
Change
- Previous filing in this sequence was filed on 02 Feb 2024.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
AMRN
transaction
Derivative
Restricted Stock Unit
Award
- Transaction value
- $0
- Shares
- +116,000
- Change %
- Price
- $0.000000
- Shares after
- 116,000
- Date
- 01 Feb 2024
- Ownership
- Direct
- Underlying class
- Ordinary Shares
- Underlying amount
- 116,000
- Exercise price
- $0.000000
- Footnotes
- F1, F2, F3, F4
AMRN
transaction
Derivative
Stock Option (right to buy)
Award
- Transaction value
- $0
- Shares
- +418,000
- Change %
- Price
- $0.000000
- Shares after
- 418,000
- Date
- 01 Feb 2024
- Ownership
- Direct
- Underlying class
- Ordinary Shares
- Underlying amount
- 418,000
- Exercise price
- $1.21
- Footnotes
- F4, F5
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 5 footnotes
Footnote F1
Each RSU represents a contingent right to receive one Ordinary Share or cash in lieu thereof at the Issuer's discretion.
Footnote F2
On February 1, 2024, the Reporting Person was granted 116,000 RSUs under the Plan. These RSUs vest in three equal installments on each of January 31, 2025, January 31, 2026 and January 31, 2027.
Footnote F3
Not applicable
Footnote F4
The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
Footnote F5
On February 1, 2024, the Reporting Person was granted an option to purchase 418,000 Ordinary Shares under the Plan. The shares subject to this option shall vest and become exercisable over three years, with 33% to vest on the first anniversary of the grant date and the balance to vest ratably over the subsequent 12 calendar quarters on the last day of each April, July, October and January.